| Literature DB >> 35601637 |
Min Chul Kim1, Amir Ben Yehuda1, Young-Woo Kim2,3, Hong Man Yoon2, Harbi Khalayleh2, Won Ho Han1, Hirokazu Noshiro4.
Abstract
Purpose: Various reconstruction methods have been proposed to reduce reflux after proximal gastrectomy, and we report here a double shouldering technique. The purpose of this study is to compare the novel double shouldering technique with conventional esophagogastrostomy in terms of short term and 3-year clinical outcome.Entities:
Keywords: Gastrectomy; Gastric cancer; Reconstructive surgical procedures
Year: 2020 PMID: 35601637 PMCID: PMC8985637 DOI: 10.7602/jmis.2020.23.4.191
Source DB: PubMed Journal: J Minim Invasive Surg
Fig. 1Schematic of the double shouldering technique: Both sides of proximal part of remnant stomach are anchored to the diaphragm by simple sutures.
Patients demographics & clinicopathological characteristics
| CEG | DS | ||
|---|---|---|---|
| Number of cases | 26 | 37 | |
| Sex | 0.723 | ||
| Male | 20 | 27 | |
| Female | 6 | 10 | |
| Age | 62.5 (9.7) | 63.6 (12.4) | 0.562 |
| BMI | 24.0 (2.1) | 24.1 (3.2) | 0.986 |
| Size of tumor | 2.5 (1.4) | 2.9 (1.4) | 0.244 |
| Location | 0.085 | ||
| High body | 14 | 14 | |
| Cardia | 7 | 20 | |
| Fundus | 5 | 3 | |
| Pathological stage (AJCC 7th) 0.054 | |||
| Ia | 23 | 25 | |
| Ib | 2 | 7 | |
| IIa | 1 | 3 | |
| IIb | 0 | 1 | |
| IIIa | 0 | 1 |
CEG = conventional esophagogastrostomy group; DS = double shouldering technique group; BMI = body mass index.
Short-term surgical outcomes
| CEG | DS | ||
|---|---|---|---|
| Number of cases | 26 | 37 | |
| Operative time (minute)[ | 196.7±83.2 | 230.5±106.0 | 0.009 |
| EBL (cc)[ | 152.5±507.2 | 78.1±175.8 | 0.537 |
| Hospital stay (day)[ | 8.5±13.4 | 10.1±13.0 | 0.005 |
| Postoperative Complications (Clavien-Dindo Classification) | 0.723 | ||
| I | 0 | 1 | |
| II | 0 | 1 | |
| IIIA | 6 | 10 | |
| IIIB | 0 | 0 | |
| IV | 0 | 0 | |
| Anastomotic complications | |||
| Anastomotic stricture | 4 (15.4%) | 4 (10.8%) | 0.707 |
| Anastomotic leakage | 1 (3.8%) | 6 (16.2%) | 0.224 |
CEG = conventional esophagogastrostomy group; DS = double shouldering technique group; EBL = estimated blood loss. *mean±2SD.
Endoscopic findings on postoperative year one and three
| CEG | DS | ||||
|---|---|---|---|---|---|
|
|
| ||||
| 1 year | 3 year | 1 year | 3 year | ||
| Number of cases | 26 | 24 | 37 | 33 | |
| Reflux esophagitis (LA classification) | 0.348/0.892/0.931/0.288 | ||||
| Normal | 19 (73.1%) | 19 (79.2%) | 31 (83.8%) | 26 (78.8%) | |
| A | 3 (11.5%) | 1 (4.2%) | 2 (5.4%) | 2 (6.1%) | |
| B | 3 (11.5%) | 4 (16.7%) | 2 (5.4%) | 2 (6.1%) | |
| C | 1 (3.8%) | 0 (0%) | 2 (5.4%) | 3 (9.1%) | |
| Bile | 0.036/0.039/0.317/1.000 | ||||
| 0 | 23 (88.5%) | 21 (87.5%) | 37 (100%) | 33 (100%) | |
| 1 | 3 (11.5%) | 3 (12.5%) | 0 (0%) | 0 (0%) | |
| Food | 0.697/0.708/0.300/0.015 | ||||
| 0 | 16 (61.5%) | 16 (66.7%) | 20 (54.1%) | 23 (69.7%) | |
| 1 | 2 (7.7%) | 1 (4.2%) | 7 (18.9%) | 3 (9.1%) | |
| 2 | 3 (11.5%) | 1 (4.2%) | 2 (5.4%) | 1 (3.0%) | |
| 3 | 5 (19.2%) | 6 (25.0%) | 8 (21.6%) | 6 (18.2%) | |
CEG = conventional esophagogastrostomy group, DS = double shouldering technique group, LA classification = Los Angeles classification. No data of postoperative 3-year endoscopic result: 2 patients in CEG group and 4 patients in DS group. *p value for comparison of postoperative 1-year result of CEG and DS group/postoperative 3-year result of CEG and DS group/CEG group of 1and 3-year result/DS group of 1and 3-year result.
Reflux symptoms for postoperative 3 years
| CEG | DS | ||
|---|---|---|---|
| Number of cases | 26 | 37 | |
| Reflux Symptom | 0.126 | ||
| Minimal | 11 (42.3%) | 11 (29.7%) | |
| Mild | 3 (11.5%) | 2 (5.4%) | |
| Moderate | 4 (15.4%) | 5 (13.5%) | |
| Severe | 8 (30.8%) | 19 (51.4%) |
CEG = conventional esophagogastrostomy group, DS = double shouldering technique group. Minimal: no complaints of reflux symptom, Mild: symptom occurs sometimes, but self limited, without hindrance to daily life, Moderate: symptoms resolve with anti-reflux medication, deprescribing of medication is possible, Severe: ongoing reflux symptoms, relapse of symptoms when discontinuing anti-reflux medication.